COMMUNIQUÉS West-GlobeNewswire

Dallas Business Journal Recognizes USOSM COO Alisa Ulrey for Leadership

25/09/2024 - 15:47

IRVING, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Dallas Business Journal has selected U.S. Oral Surgery Management (USOSM) Chief Operations Officer Alisa Ulrey as a 2024 C-Suite Leaders Awards program honoree. The C- [...]

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study

25/09/2024 - 15:15

- Patients are preselected for CDKN2A and/or CDKN2B abnormalities - - Safety and efficacy data to be reported at an upcoming oncology medical conference - BERKELEY HEIGHTS, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- [...]

ClinicalTrials.EU platform rolled out across Europe

25/09/2024 - 15:14

LONDON, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The European Clinical Trials Information Network ( ClinicalTrials.EU ) has today announced its official rollout across the continent. The patient-centric platform aims to solve [...]

Koelis Announces New Compact 3D Probe to Improve Workflow and Reprocessing

25/09/2024 - 15:07

New 3D Ultrasound Probe maximizes auto reprocessing compatibility New probe adaptor improves needle guidance for targeted biopsy and treatment GRENOBLE, France and PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- [...]

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

25/09/2024 - 15:02

Please see enclosed pdf. Attachment 25092024_trading_in_shares_N_P_Louis-Hansen_ApS

InBrain Pharma to Present Positive Results from Its DIVE-I Phase I/II Clinical Trial for Parkinson’s Disease at the Congress of Parkinson’s Disease and Movement Disorders from September 27 to October 1 in Philadelphia

25/09/2024 - 15:00

Lille, September 25, 2024 - InBrain Pharma, a biopharmaceutical company specialized in neurodegenerative diseases, will present the positive results of its Phase I/II DIVE-I clinical trial for Parkinson’s disease at the [...]

Sanner Group acquires Gilero to expand its global medical device offering

25/09/2024 - 15:00

Sanner Group acquires Gilero to expand its global medical device offering Acquisition drives Sanner Group’s mission to offer a suite of world leading development and manufacturing services for its customers across the [...]

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

25/09/2024 - 15:00

VANCOUVER, British Columbia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ” or the “ Company ”) provides the following update: Dear Shareholders, We are [...]

GoLiver Therapeutics is the winner of the France 2030 “innovation in Biotherapies and Bioproduction” call for its GOCLINICALS project, dedicated to a novel stem cell-based liver therapy

25/09/2024 - 15:00

Press release GoLiver Therapeutics has been awarded €1.6m from France 2030 to progress its first biomedicine, developed from pluripotent stem cells, into the clinic for the treatment of severe liver failures. Nantes, [...]

QHSLab Secures Grant Sponsorship from a Global Leader in Consumer Health to Advance Digital Medicine Tools for Allergy Management in the Primary Care Setting

25/09/2024 - 15:00

WEST PALM BEACH, FL, Sept. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based [...]

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy

25/09/2024 - 14:55

– Through selective inhibition of proinflammatory transcription, p300 KAT inhibition modulates the activity and function of multiple pro-inflammatory signaling pathways that drive chronic inflammatory diseases – – Oral [...]

GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment

25/09/2024 - 14:45

Live video webcast on Wednesday, October 2 nd at 12:00 PM ET LA JOLLA, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an [...]

Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients

24/09/2024 - 22:20

LOS ANGELES, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces a groundbreaking collaboration with PreCheck Health Services Inc., a CLIA- [...]

Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2024 Conference Call for Monday, September 30, 2024

24/09/2024 - 22:15

GARDNER, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]

LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

24/09/2024 - 22:05

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]

Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day

24/09/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with [...]

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

24/09/2024 - 22:05

-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict the risk of preeclampsia in pregnant women- -The PrePsia test can [...]

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

24/09/2024 - 22:01

CAMBRIDGE, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]

Highmark, US Digestive Health Reach New Contract Agreement

24/09/2024 - 21:08

PITTSBURGH and EXTON, Pa., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Highmark and US Digestive Health have announced that the two organizations reached agreement on a new five-year contract that ensures long-term, in-network [...]